Animal research ethics is the framework of principles, oversight bodies, and law that determines when and how vertebrate animals may be used in research, teaching, and testing in the United States. It is not a single document or agency — it is the combined product of a scientific ethical principle (the 3Rs), a federal statute (the Animal Welfare Act), a funding-agency policy (PHS Policy), and an institutional oversight committee (the IACUC), each covering a different slice of the same activity. This guide lays out how those pieces fit together, who is responsible for what, and where to go for the operational detail on each.
This page consolidates the general “animal research ethics” / “ethics of animal research” search intent into a single reference — for the mechanics of any one piece, follow the links to CASRAI’s dedicated pages on the 3Rs, the Animal Welfare Act, PHS Policy, and the IACUC.
The ethical foundation: why animal research is regulated at all
The ethical case for regulating animal research rests on a cost-benefit judgment: animal use is permitted only where the scientific or educational benefit justifies the harm to the animal, and only after less-harmful alternatives have been considered. That judgment is not left to individual investigators to make alone — it is built into the review process itself, most concretely through the 3Rs and through mandatory independent committee review before any animal work begins.
The 3Rs: Replacement, Reduction, Refinement
The 3Rs — Replacement, Reduction, and Refinement — are the organizing ethical principle behind essentially every animal-research oversight framework in use today. They were first articulated by William Russell and Rex Burch in their 1959 book The Principles of Humane Experimental Technique, and remain the conceptual backbone of both the Guide for the Care and Use of Laboratory Animals and IACUC protocol review:
- Replacement — using non-animal or lower-order alternatives (in vitro assays, computational models, cell-based systems) wherever they can answer the scientific question.
- Reduction — using the minimum number of animals consistent with valid, statistically sound results.
- Refinement — minimizing pain, distress, and suffering for the animals that are used, through anesthesia, analgesia, humane endpoints, and improved husbandry.
IACUCs are required to apply the 3Rs at the protocol-review stage: investigators must justify species and animal numbers and describe consideration of non-animal alternatives before a protocol is approved. The “Replacement” principle has gained new regulatory weight since the FDA Modernization Act 2.0 (signed December 2022) removed the statutory requirement that safety and efficacy data for a drug come specifically from animal studies, and FDA’s 2025 roadmap for reducing reliance on animal testing in preclinical safety studies frames New Approach Methodologies (NAMs) — organ-on-chip systems, in vitro assays, and computational models — as the practical embodiment of Replacement.
Who actually reviews and approves animal research: the IACUC
In the US, no animal research covered by federal law or policy can begin without prior approval from the institution’s Institutional Animal Care and Use Committee (IACUC). This is the animal-research equivalent of IRB review for human subjects research, and functions as the point where the ethical principles above actually get applied to a specific protocol.
Under 9 CFR 2.31, a research facility’s CEO must appoint an IACUC of at least three members, including one veterinarian with laboratory-animal training or experience and one member unaffiliated with the institution (a “community member”). The IACUC:
- reviews and approves (or requires modification of) animal-use protocols before any work begins, applying the 3Rs criteria described above;
- conducts a semiannual program review and facility inspection, documenting deficiencies and corrective timelines;
- has authority to suspend an approved activity if it finds the work is not being conducted as approved;
- oversees the attending veterinarian‘s program of veterinary care and the institution’s occupational health program for personnel with animal contact.
For the administrative detail of running an IACUC program — protocol categories, inspection cycles, member training — see CASRAI’s IACUC Training guide.
The two federal frameworks: Animal Welfare Act vs. PHS Policy
Two separate federal frameworks anchor animal research oversight in the US, and they do not cover exactly the same animals or institutions. Confusing the two, or assuming one supersedes the other, is one of the most common compliance mistakes in this space.
| Animal Welfare Act (AWA) | PHS Policy | |
|---|---|---|
| Legal form | Federal statute (7 U.S.C. 2131–2159) with implementing regulations at 9 CFR | Funding-agency policy, not a statute |
| Enforced by | USDA / APHIS, via registration and on-site inspection | NIH Office of Laboratory Animal Welfare (OLAW), via each institution’s Animal Welfare Assurance |
| Triggered by | Use of a covered species at a covered facility, regardless of funding source | Receipt of PHS funding (including NIH), regardless of species covered |
| Species covered | Excludes purpose-bred rats, mice, and birds, and excludes farm animals used for agricultural purposes | Covers essentially all live vertebrate animals, including purpose-bred rats, mice, and birds |
Because PHS Policy covers species the AWA excludes, the two frameworks are complementary rather than redundant — an institution doing NIH-funded rodent work is bound by PHS Policy even though that same work sits outside AWA jurisdiction. See the full detail on the Animal Welfare Act and PHS Policy for the exclusions and Assurance mechanics.
The Guide for the Care and Use of Laboratory Animals
Neither the AWA nor PHS Policy specifies detailed husbandry and welfare practice on its own. Both incorporate by reference the Guide for the Care and Use of Laboratory Animals (the “Guide”), an NRC/ILAR consensus document, currently in its 8th edition (2011), published by the National Academies Press. The Guide is not itself a regulation — it becomes binding through PHS Policy (as the standard institutions attest to follow under their Assurance) and through voluntary AAALAC accreditation. Agricultural species used for agricultural-production research instead typically follow the parallel Ag Guide, which fills the welfare-standard gap left by the AWA’s exclusion of farm animals used for food and fiber purposes.
Voluntary accreditation: AAALAC International
AAALAC International provides voluntary, triennial site-visit accreditation to institutions that choose to demonstrate compliance above the regulatory floor. Accreditation is not required by any US law or funding regulation, but many institutions pursue it as an independent signal of program quality, and some funders and journals treat it as a relevant factor. Roughly 1,000 organizations worldwide currently hold AAALAC accreditation.
How the pieces fit together
In practice, an investigator proposing a study using PHS-funded, purpose-bred mice at a US university encounters all of these layers at once: the study must be reviewed and approved by the IACUC before it begins (applying 3Rs criteria); the institution’s animal-care program must be conducted consistent with the Guide, per its PHS Assurance with OLAW; and if the species or facility also falls under AWA jurisdiction, USDA/APHIS inspection applies as well. The institution may additionally hold AAALAC accreditation on top of these mandatory layers. No single document explains the whole system end to end — that overlap is precisely why research-ethics oversight in this area is described as “layered” rather than governed by one central regulator.
Frequently asked questions
What are the 3Rs in animal research ethics?
Replacement (using non-animal alternatives where possible), Reduction (using the minimum number of animals for valid results), and Refinement (minimizing pain and distress for animals that are used). They were first proposed by Russell and Burch in 1959 and are applied at the IACUC protocol-review stage.
Who oversees animal research ethics in the US?
Primary day-to-day oversight sits with each institution’s IACUC, which reviews and approves protocols and inspects facilities. Above that, USDA/APHIS enforces the Animal Welfare Act for covered species, and NIH’s Office of Laboratory Animal Welfare oversees PHS Policy compliance for PHS-funded institutions. AAALAC International adds a voluntary accreditation layer on top of both.
Does the Animal Welfare Act cover mice and rats?
No — the AWA’s regulatory definition of “animal” excludes purpose-bred rats, mice, and birds used in research, which make up the large majority of research animals in the US. Those species are instead covered through PHS Policy for institutions receiving PHS/NIH funding, or may fall outside federal coverage entirely at institutions with no PHS funding and no AWA-covered species.
Is animal testing required by the FDA?
Historically, yes, for most drug safety and efficacy data, but this has changed. The FDA Modernization Act 2.0 (December 2022) removed the statutory requirement that safety and efficacy data come specifically from animal studies, permitting sponsors to submit non-animal data such as cell-based assays or computational models where scientifically justified. FDA’s April 2025 roadmap sets a multi-year ambition to reduce animal testing in preclinical safety studies, starting with monoclonal antibodies and biologics.
Is AAALAC accreditation legally required?
No. AAALAC accreditation is voluntary and distinct from the mandatory Animal Welfare Act and PHS Policy frameworks. No US law or funding regulation requires it, though many institutions pursue it as an independent quality signal.
What happens if an institution violates animal research ethics requirements?
Consequences depend on which framework is implicated. USDA/APHIS can cite AWA violations found during inspection and, in serious cases, pursue enforcement action against a registered research facility. For PHS Policy, an institution’s IACUC must report serious or continuing noncompliance, serious deviations from the Guide, or any IACUC-ordered suspension of an activity to OLAW, which can restrict or withdraw an institution’s Assurance — effectively cutting off its ability to receive PHS funding for animal research.
